N60.29
Fibroadenosis of unspecified breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Fibroadenosis of the breast, also known as fibrocystic breast changes, is a common benign (non-cancerous) condition characterized by various changes in breast tissue. It often causes discomfort and noticeable lumps or thickening, primarily affecting women in their reproductive years. Although the exact cause remains unclear, hormonal fluctuations are believed to play a significant role. The ICD-10 code N60.29 is used for diagnosing unspecified fibroadenosis of the breast, indicating that the condition involves fibrocystic changes without a more specific categorization.
Causes & Symptoms
Clinical Causes: Hormonal fluctuations, especially involving estrogen and progesterone Caffeine intake and certain dietary factors Genetic predisposition or family history Hormonal replacement therapy or oral contraceptive use Lifestyle factors such as stress or irregular menstrual cycles Environmental influences and exposure to endocrine-disrupting substances
Key Symptoms: Lumps or thickened areas in one or both breasts Breast tenderness or pain, often fluctuating with menstrual cycle Changes in breast size or shape Swelling or a feeling of heaviness in the breasts Nodular or lumpy texture when feeling the breasts Discomfort that commonly worsens before menstruation and improves afterward
Diagnostic & Treatment
Diagnosis Path: Diagnosis of fibroadenosis of the breast typically involves a combination of clinical examination and imaging studies. The key diagnostic steps include: - **Medical history assessment** regarding symptom patterns and menstrual cycles. - **Physical examination** to identify lumps, thickening, or areas of tenderness. - **Imaging techniques** such as mammography or ultrasonography to visualize cystic or fibrous changes. - **Fine needle aspiration or biopsy** in cases where there is uncertainty or suspicion of other conditions. Since the condition is benign, additional tests are usually aimed at ruling out other breast abnormalities or malignancies.
Treatment Protocols: Management of fibroadenosis is typically conservative, focusing on symptom relief and monitoring. Treatment options include: - **Lifestyle modifications:** Reducing caffeine intake and maintaining a balanced diet. - **Symptomatic relief:** Over-the-counter pain relievers and supportive bras. - **Hormonal therapy:** In some cases, hormonal medications may be prescribed to regulate symptoms. - **Regular monitoring:** Periodic clinical examinations and imaging if necessary. - **Patient education:** Reassurance about the benign nature of the condition and guidance on self-examination. Surgical intervention is rarely required unless there are persistent or suspicious lumps that need further evaluation.
Clinical Advice & FAQs
Billing Guidance
Is N60.29 a billable ICD-10 code?
Yes, N60.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N60.29?
Clinical documentation must specify the nature of Fibroadenosis of unspecified breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference